Notable FDA

FDA Seeks OMB Clearance for Medical Device Adverse Event Reporting Program (MedSun)

FDA's submission of the MedSun information collection for OMB review signals continued focus on post-market surveillance of medical devices through structured adverse event reporting. The Food and Drug Administration has submitted a proposed information collection request to the Office of...

The deep analysis — cross-item commentary and how this topic has evolved — is part of SignalHealth Pro.

Start a 14-day Pro trial — $9/month

Trust record

Agent curated